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Very fast amplification of DNA in small volumes can be continuously monitored with a rapid cycler that
incorporates fluorimetric detection. Primers were designed to amplify a 157-bp fragment of the rpoB gene
spanning codons 526 and 531 and a 209-bp fragment of the katG gene spanning codon 315 of Mycobacterium
tuberculosis. Most mutations associated with resistance to rifampin (RMP) and isoniazid (INH) in clinical
isolates occur in these codons. Two pairs of hybridization probes were synthesized; one in each pair was 3*
labeled with fluorescein and hybridized upstream of the codon with the mutation; the other two probes were
5* labeled with LightCycler-Red 640. Each pair of probes recognized adjacent sequences in the amplicon. After
DNA amplification was finished by using a LightCycler, the temperature at which the Red 640 probe melted
from the product was determined in a 3-min melt program. Twenty M. tuberculosis clinical isolates susceptible
to streptomycin, INH, RMP, and ethambutol and 36 antibiotic-resistant clinical M. tuberculosis isolates (16
resistant to RMP, 16 to INH, and 4 to both antimicrobial agents) were amplified, and the presence of mutations
was determined using single-strand conformation polymorphism analysis, the LiQor automated sequencer,
and the LightCycler system. Concordant results were obtained in all cases. Within 30 min, the LightCycler
method correctly genotyped all the strains without the need of any post-PCR sample manipulation. Overall,
this pilot study demonstrated that real-time PCR coupled to fluorescence detection is the fastest available
method for the detection of RMP and INH resistance-associated mutations in M. tuberculosis clinical isolates.
The emergence of drug-resistant strains of Mycobacterium
tuberculosis is an increasing problem for populations and tu-
berculosis control programs in developed and developing
countries alike. Today, rifampin (RMP) and isoniazid (INH)
are important components of effective multidrug therapy and
prophylaxis for M. tuberculosis infections. However, wide-
spread use of these agents and failure of patients to complete
prescribed treatment have led to the emergence of RMP- and
INH-resistant strains (5, 7). RMP resistance is well character-
ized, and 95% of all M. tuberculosis RMP-resistant clinical
isolates harbor specific mutations within an 81-bp region of the
rpoB gene, which encodes the b subunit of the RNA polymer-
ase (8, 18). In contrast to RMP, genotypic testing for INH
resistance is much more complex. Several studies have re-
ported alterations in at least four genes, katG, inhA, ahpC, and
kasA (1, 10, 12, 21, 24). Although the importance of katG
mutations in INH resistance has been clearly demonstrated,
the involvement of the other genes is arguable (6, 10, 11, 15).
The highest proportion of mutations is in the katG gene, but
only some mutations in this gene have been associated with
high-level resistance (e.g., deletions or S315T), whereas others
do not appear to confer any resistance to INH (e.g., R463L).
The need to minimize the transmission of drug-resistant
strains requires rapid identification procedures. Due to their
high sensitivity and specificity, DNA assays have the potential
to provide rapid detection of resistance in mycobacterial iso-
lates. Because these procedures do not rely on in vitro growth,
the time between diagnosis and the onset of effective therapy is
shortened.
In this report we present a single-tube method for detecting
mutations associated with resistance to RMP and INH. It com-
bines both rapid-cycle PCR and real-time monitoring of the
processing and generation of mutation-specific, fluorescent-
probe melting profiles on the LightCycler (Roche Biochemi-
cals). Two fluorescently labeled hybridization probes recogniz-
ing adjacent sequences in the amplicon were present in the
reaction mixture. The shorter detection probe (sensor [59-
LightCycler-Red 640 labeled]) covers the predicted site of mu-
tation, while the longer probe (anchor [39 fluorescein labeled])
produces the fluorescent signal. After annealing, the fluoro-
phores are in close proximity and there can be a fluorescence
resonance energy transfer between them, providing real-time
monitoring of the amplification process. When PCR was com-
pleted, fluorescence was monitored as the temperature was
increased through the melting temperature (Tm) of the probe-
product duplexes, and a characteristic melting profile for each
genotype was obtained. We used two different pairs of
probes—one designed to detect the two most frequent muta-
tions, Ser531Leu (a change in codon 531 from coding serine to
leucine [TCG3TTG]) and His526Asp (a change in codon 526
from coding histidine to aspartic acid [CAC3GAC]) in the
rpoB gene related to RMP resistance, and the other designed
to detect the most frequent mutation (in codon 315) related to
INH resistance in the katG gene. With this method one strain
could be genotyped within 30 min without any post-PCR sam-
ple manipulation.
MATERIALS AND METHODS
Strains and resistance testing. Twenty susceptible and 36 resistant clinical
isolates of M. tuberculosis (16 resistant to RMP, 16 to INH, and 4 to both), as
determined by the radiometric dilution method (23), from 56 different patients
were studied. By this method, drug resistance was defined as greater than 1%
growth in the presence of 2 mg of streptomycin per ml, 0.2 mg of INH per ml, 2
mg of RMP per ml, or 5 mg of ethambutol per ml. Isolates that were found to be
resistant by this method were retested by the proportion method before being
reported as resistant (23).
Relatedness of all resistant strains was investigated by restriction fragment
length polymorphism of the IS6110 element (16). All the strains had different
IS6110 fingerprint patterns. M. tuberculosis H37Rv (susceptible), M. tuberculosis
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ATCC 35838 (RMP resistant), and M. tuberculosis ATCC 35822 (INH resistant)
were used as controls.
Extraction of mycobacterial DNA from the strains. A rapid DNA extraction
procedure for direct testing of M. tuberculosis on Löwenstein-Jensen solid me-
dium was performed as follows. One 10-ml loop of the organisms was suspended
in 100 ml of sterile water, and subsequently 100 ml of a 10% suspension of Chelex
100 was added (20). After thorough mixing, the mixture was incubated at 45°C
for 45 min, then the suspension was boiled for 5 min, and the bacterial debris was
removed by centrifugation (12,000 3 g for 5 min). The supernatant was directly
used for amplification.
Conventional PCR. The DNA preparation was amplified with the primers
listed in Table 1. PCR primers were designed to amplify the regions between
nucleotides 2335 and 2492 of the rpoB gene and nucleotides 2759 and 2967 of the
katG gene (19). Conditions for cycling were 95°C for 45 s followed by 35 cycles
of 95°C for 15 s, 55°C (annealing temperature for the rpoB gene) and 60°C
(annealing temperature for the katG gene) for 15 s, and 72°C for 15 s in a 9600
Perkin Elmer apparatus. PCR products were purified by using the Sephaglas
BandPrep kit (Amersham Pharmacia Biotech).
PCR-single-strand conformation polymorphism analysis (3). After amplifica-
tion by the same PCR protocol as above, 50 ng of the purified PCR product was
mixed 1:1 with at least 2 ml of loading buffer (99% formamide–5 mM EDTA–
0.5% bromophenol blue), heated for 10 min at 95°C, cooled on ice, and loaded
in a precast, ready-to-use gel (Genegel Excel 12,5/24 kit; Amersham Pharmacia
Biotech). Electrophoresis was run on a GenePhor electrophoresis unit at 600 V,
25 mA, 15 W, and 15°C for about 80 min (until bromophenol blue reached the
anode buffer strip). Gels were stained in a Hoefer automated gel stainer with
PlusOne DNA silver stain (Amersham Pharmacia Biotech). This method was
used as part of the characterization of resistant strains.
DNA sequencing. Direct sequencing of PCR products of all the strains was
performed with a LiQor automated sequencer and corresponding kits from the
same manufacturer (Roche Biochemicals).
LightCycler. All DNA extracts were amplified with the primers used in con-
ventional PCR, with the addition of the fluorescein- and Red 640-labeled probes
to the amplification mix. The probes were designed as shown in Fig. 1. For rpoB
the 59-Red 640-labeled probe (rpo sensor) covered the region containing codons
526 and 531. To avoid dimer formation between primer TR8 and the rpo anchor
probe, a G3T substitution at position 2407 (GenBank accession number
L27989) was introduced in the 39 terminus of the rpo anchor probe. There was a
four-base gap between the rpo sensor and the 39-fluorescein-labeled probe (rpo
anchor). The theoretical Tms were 61 and 68.4°C for TR9 and TR8 primers,
respectively, and 70.4 and 73.8°C for the rpo sensor and rpo anchor probes,
respectively. For the katG gene, the 59-Red 640-labeled probe (katG sensor)
covered the region containing codon 315. There was a two-base gap between the
katG sensor and the 39-fluorescein-labeled probe (katG anchor). The theoretical
Tms were 64.3 and 62.8°C for TB86 and TB87 primers, respectively, and 69.4 and
75.3°C for katG sensor and katG anchor probes, respectively (Table 1). Thus, the
Red 640-labeled probes should melt from the PCR product at a lower temper-
ature than the fluorescein-labeled probes so that the fluorescence observed is a
measure of the Red 640-labeled probes. All primers and probes were designed
and synthesized by TIB MOLBIOL (DNA Synthesis Service; Roche Diagnostics,
Berlin, Germany).
The components for PCR in a final volume of 20 ml included 2 ml of a
commercial ready-to-use reaction mix for PCR (LightCycler-DNA master hy-
bridization probes; Roche Diagnostics) that contains Taq DNA polymerase,
reaction buffer, deoxynucleoside triphosphate mix, and 10 mM MgCl2. We added
MgCl2 to a final concentration of 4 mM. The primers and probes were added to
final concentrations of 0.5 and 0.2 mM, respectively. Finally, we used 2 ml of
template DNA. The 20-ml (final volume) reaction mix was placed in glass cap-
illary cuvettes which were filled by pulse centrifugation in a microcentrifuge.
Conditions for cycling were 95°C for 45 s, followed by 35 cycles of 95°C for 1 s,
55°C (annealing temperature for the rpoB gene) and 60°C (annealing tempera-
ture for the katG gene) for 2 s, and 72°C for 6 s, with monitoring of fluorescence
during the annealing phase; this, in turn, was followed by a melting program of
50 to 85°C at 0.1°C/s with continuous monitoring of the fluorescence.
RESULTS
Rapid PCR and continuous monitoring of product. The
accumulation of PCR product was monitored by measuring the
level of fluorescence. Figure 2 shows the progress of PCR with
Chelex 100-extracted DNA as the template. The PCR product
was observed to accumulate in an exponential manner, indi-
cating an optimal PCR. It can be seen that the signals started
to rise at different times, usually between cycle numbers 15 and
25, because we did not estimate the DNA concentration and
FIG. 1. Design of fluorescent probes for mutation detection in the rpoB (A)
and katG (B) genes in the LightCycler. The probes are designed so that the Red
640-labeled probe will detach at a lower temperature than the fluorescein-
labeled probe. Primers were those described by Telenti et al. (19).
TABLE 1. Oligonucleotides—primersa and probes—used in the amplification and detection protocol by PCR of the M. tuberculosis strains





rpoB TR8, 59-GTGCACGTCGCGGACCTCCA 2492 158 55 68.4
TR9, 59-TCGCCGCGATCAAGGAGT 2335 61.0
rpoB rpo sensor, 59-640c-ACCCACAAGCGCCGACTGCTGG-Phosd 2412 70.4
rpo anchor, 59-TTCATGGACCAGAACAACCCGCTGTCGGT-39Fe 2379 73.8
katG TB86, 59-GAAACAGCGGCGCTGATCGT 2759 209 60 64.3
TB87, 59-GTTGTCCCATTTCGTCGGGG 2967 62.8
katG TB sensor, 59-640c-TCACCAGCGGCATCGAGGTCGT-Phosd 2916 69.4
TB anchor, 59-CGTATGGCACCGGAACCGGTAAGGACGC-39Fe 2886 75.3
a Primer sequences were described by Telenti et al. (19).
b The positions of the oligonucleotides correspond to GenBank accession number L27989 for the rpoB gene and accession number X68081 for the katG gene.
c 640, LightCycler-Red 640 is a fluorophore with maximum absorbance at 622 nm and maximum emission at 638 nm.
d The 39 terminus of the sensor probe was phosphorylated to prevent extension of the probes during PCR.
e F, fluorescein.
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started with different amounts of DNA. This did not affect the
interpretation of the Tm. We used the same primers for “con-
ventional” PCR and LightCycler, because our target was small
enough that this rapid cycling protocol worked well.
Tms of the probes. The temperatures at which the probes
melted from PCR products during the melting program were
calculated using the LightCycler software. A summary of the
Tms for all of the probes (RMP and INH) together with the
changes in Tm for the products derived from resistant and
susceptible M. tuberculosis strains is shown in Table 2.
We were able to detect the two most frequent mutations
responsible for RMP resistance, using the RMP probe (rpo
sensor) (Fig. 3). The Tm for the susceptible strain used as a
control (M. tuberculosis H37Rv) was 64.3°C, while the change
from wild type to mutant at codon 531 (TCG3TTG) in 18
strains resulted in a .2°C increase in the probe’s Tm. In the
two strains with mutations at codon 526 (CAC3GAC), we
observed a .6°C drop in the probe’s Tm.
Figure 4 shows the results with the INH probe (katG sen-
sor). The Tm for the susceptible strain (M. tuberculosis H37Rv)
was 72.8°C. The change from wild type (AGC) to ACC at
codon 315 in 18 strains resulted in a .3°C drop of Tm of the
katG sensor probe. A drop of almost 5°C in the Tm was found
in two strains harboring a different mutation at codon 315
(AGC3AAC).
All the susceptible M. tuberculosis strains, determined by
using either the rpo sensor or the katG sensor probe, showed a
Tm that corresponded to the susceptible strain used as control
(M. tuberculosis H37Rv). In addition, the sequence inferred
from the LightCycler data was always in accordance with the
nucleotide sequencing and the single-strand conformational
polymorphism pattern.
DISCUSSION
Due to the slow growth of the M. tuberculosis bacillus, un-
acceptable delays in the diagnosis of drug-resistant tuberculo-
sis can occur when conventional culture-based susceptibility
tests are used. Understanding the genetic events that lead to
drug resistance in clinical M. tuberculosis isolates is important
for elucidation of the action of antimicrobial agents, for design
of novel antibiotics that are active against drug-resistant
strains, and for development of genetic assays to be adapted to
the routine clinical mycobacteriology laboratory. Rapid ap-
proaches that use genetic analysis for detection of mutations
associated with drug resistance have been proposed (4, 9, 13,
15, 19). However, these methods have restricted applicability
in clinical laboratories and are mainly limited to the detection
of RMP resistance.
The method described here provides a rapid, accurate, and
inexpensive way to detect resistance in M. tuberculosis clinical
isolates. Amplification, hybridization, and analysis are all per-
formed simultaneously in sealed capillary tubes. The entire
assay, including analysis, can be completed in 30 min. In all
cases, the result obtained with the LightCycler corresponded to
nucleotide sequence data; therefore, unlike many other nucleic
FIG. 2. Accumulation of Red 640 fluorescence during PCR using the katG anchor and sensor probes with three different samples: M. tuberculosis H37Rv strain
(susceptible) and R27 and R30 M. tuberculosis strains (INH resistant). NC, negative control. F2 is the channel used by the LightCycler to detect the LightCycler-Red
640 light emission.
TABLE 2. Tms for RMP and INH mutation detection probes
Antimicrobial
agent
Mean probe Tm (°C) 6 SD for strain or mutationa
Wild typeb 531 (TCG3TTG) 526 (CAC3GAC) 315 (AGC3ACC) 315 (AGC3AAC) Susceptible strains
RMP 64.3 6 0.4 66.9 6 0.5c (18) 58.1 6 0.2 (2) 64.4 6 0.6 (20)
INH 72.8 6 0.5 68.7 6 0.4c (18) 67.9 6 0.07 (2) 72.4 6 0.4 (20)
a Means were derived from at least three determinations. Numbers in parentheses are numbers of strains tested.
b M. tuberculosis H37Rv (susceptible).
c Four strains were RMP and INH resistant.
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amplification tests (14), the LightCycler amplification assay
was 100% specific. This was likely due to the closed-well pro-
tocol, which eliminates amplicon carryover. Theoretically, it is
possible that natural variability in the sequences where the
sensor probes bind could lead to a change in the Tm of the
probe that is not associated with resistance mutation. How-
ever, previous studies (17) have suggested that the DNA se-
quences of M. tuberculosis are extraordinarily well conserved
and that mutations in the M. tuberculosis genome are almost
always associated with drug resistance. This fact makes this
method even more useful for resistance detection in M. tuber-
culosis.
With the RMP probe used in this study, we were able to
detect mutations at codon 531 and codon 526. We previously
reported (6) that these were the two most frequent residue
changes associated with RMP resistance in our study area, and
this finding was similar to previous studies (8, 18). Based on
our mutation data from strains isolated in the last 6 years (6;
FIG. 3. Derivative melting curves (dF/dT) of Red 640-labeled rpo sensor probe with three different samples. This sensor probe was designed to have the sequence
CTG at codon 531 and the wild-type sequence (CAC) at codon 526. Strains: H3TRv, M. tuberculosis H37Rv strain (susceptible) with a double mismatch at codon 531
(TCG) resulting in a Tm of 64.4°C; R4, M. tuberculosis R4 strain (RMP resistant) with a 531-codon point mutation (TCG to TTG), which has a higher Tm of 66.9°C
showing a single mismatch; R15, M. tuberculosis R15 strain (RMP resistant) with a 526-codon point mutation (CAC to GAC), which has the lower Tm due to the three
mismatches, one at codon 526 and two at codon 531. Each trace shows the change in fluorescence ratio with time with respect to temperature, thus allowing calculation
of the temperature at which the probe detaches from the PCR product. F2 is the channel used by the LightCycler to detect the LightCycler-Red 640 light emission;
F1 is the channel measuring the background.
FIG. 4. Derivative melting curves of Red 640-labeled katG sensor probe with three different samples: M. tuberculosis H37Rv strain (susceptible) with a perfect match
to the hybridization probe and a Tm of 72.8°C; M. tuberculosis strain R30 (INH resistant) with the mutation AGC 3 ACC at codon 315, and a Tm of 68.7°C; and M.
tuberculosis strain R27 with the mutation AGC 3 AAC at codon 315 and a Tm of 67.9°C. Each trace shows the change in fluorescence ratio over time with respect
to temperature, thus allowing calculation of the temperature at which the probe detaches from the PCR product. F2 is the channel used by the LightCycler to detect
LightCycler-Red 640 light emission; F1 is the channel measuring the background.
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unpublished data), if we used an additional probe covering
codons 513 and 518, the sensitivity for the detection of RMP
resistance would be greater than 95%.
In contrast to RMP resistance testing, genotypic testing for
resistance to INH presents many difficulties. Our understand-
ing of the genetic basis of INH resistance is far from complete.
Changes in the katG gene, the inhA gene, and the ahpC gene
in INH-resistant mycobacterial isolates have been described.
The importance of katG mutations in INH resistance is well
established, although the extent to which such mutations ac-
count for the spectrum of resistance is still debated. Missense
mutations at codon 315 of the katG gene have been reported in
almost two-thirds of the INH-resistant isolates from different
geographic areas including ours (6, 13, 19). The high percent-
age of mutations at position 315 and the occurrence of differ-
ent nonsynonymous substitutions demonstrate the importance
of this codon for the development of INH resistance among M.
tuberculosis strains. Mutations at other positions seem to be
rare events. In addition, many of these do not alter enzyme
activity, and usually it is suggested that they are involved in the
resistance mechanism simply because no other katG gene mu-
tations were observed. For all these reasons, we decided to
assess the utility of this new method by using a probe to screen
for the presence of mutation in a selected region of the katG
gene that includes position 315. The specificity of the test was
100%, and the Tm of the probe allowed the two mutations
studied to be distinguished.
We are working on the development of a probe to screen for
mutations in the regulatory region of the inhA gene that cause
overexpression of this gene. However, in our sample popula-
tion, we found this alteration (nucleotide substitution at posi-
tion 209 [C3T]) in only 10% of the strains, and there is still
some controversy about the implication of this gene in INH
resistance (11).
The presence of mutations in either of these two genes (i.e.,
katG or inhA) would account for INH resistance, but, accord-
ing to previous studies on different populations (15), between
20 and 60% of resistant strains have no detectable mutations in
those genes. Therefore, more research is needed to elucidate
the remaining cases of resistant strains that cannot be attrib-
uted to the above-mentioned mutations in katG and inhA
genes. Furthermore, in both RMP and INH resistance, the
relative frequency of particular (i.e., rare) mutations may re-
flect local strain populations and/or epidemic strains. Thus,
determination of the frequency of mutations underlying drug
resistance in isolates from different geographic areas has to be
the basis for developing rapid and specific techniques for the
detection of drug-resistant strains by molecular genetic tech-
niques.
This new method presents several advantages. First, rapid
amplification and analysis allow the test to be completed within
30 min. Because the DNA extraction procedure requires 1 h,
the whole detection can be completed in less than 2 h. Second,
the LightCycler optical device is capable of measuring fluores-
cence in two separate channels simultaneously (Red 640 and
Red 705 Fluorophore), and it is possible to use Sybr Green I as
a generic donor of fluorescence resonance energy transfer (2,
22) (instead of a specific fluorescein probe), thus allowing
analysis of different mutations within a single test tube. Third,
the assay is run in closed glass capillaries. Postamplification
analysis can be performed without opening the capillaries,
minimizing the risk of carryover contamination. Fourth, the
LightCycler could be used to determine the genetic make-up of
some bacterial populations composed of subpopulations with
different genotypes. Fifth, the method can be adapted to geno-
typing resistance information emerging from the identification
of additional targets, particularly for INH resistance.
Finally, we emphasize that this is the first time that real-time
PCR has been employed to study resistance in M. tuberculosis
clinical isolates. Reliable results can be obtained faster than
with any other current molecular methods and could be di-
rectly applied to clinical samples.
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